• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 31, 2022

    3/31/22 5:25:32 AM ET
    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Multi-Sector Companies
    Miscellaneous
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACTG alert in real time by email

     

    Companies Reporting Before The Bell

    • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

    • Perma-Fix Envirn Servs (NASDAQ:PESI) is likely to report earnings for its fourth quarter.

    • Recruiter.Com Group (NASDAQ:RCRT) is projected to report quarterly loss at $0.38 per share on revenue of $8.77 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is likely to report quarterly loss at $0.01 per share on revenue of $29.80 million.

    • Welltower (NYSE:WELL) is projected to report quarterly loss at $0.03 per share on revenue of $112.79 million.

    • Renalytix (NASDAQ:RNLX) is projected to report quarterly loss at $0.17 per share on revenue of $500.00 thousand.

    • 1847 Goedeker (AMEX:GOED) is projected to report quarterly earnings at $0.05 per share on revenue of $145.00 million.

    • Celsion (NASDAQ:CLSN) is likely to report quarterly loss at $0.90 per share on revenue of $120.00 thousand.

    • Acacia Research (NASDAQ:ACTG) is likely to report quarterly loss at $0.04 per share on revenue of $5.00 million.

    • Affimed (NASDAQ:AFMD) is projected to report quarterly loss at $0.17 per share on revenue of $8.57 million.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is estimated to report earnings for its fourth quarter.

    • Dare Bioscience (NASDAQ:DARE) is likely to report quarterly loss at $0.15 per share on revenue of $1.25 million.

    • Smith-Midland (NASDAQ:SMID) is expected to report earnings for its fourth quarter.

    • Walgreens Boots Alliance (NASDAQ:WBA) is expected to report quarterly earnings at $1.38 per share on revenue of $33.36 billion.

    • Taysha Gene Therapies (NASDAQ:TSHA) is projected to report earnings for its fourth quarter.

    • Jiayin Gr (NASDAQ:JFIN) is likely to report earnings for its fourth quarter.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report quarterly loss at $0.11 per share on revenue of $7.79 million.

    • Blonder Tongue (AMEX:BDR) is estimated to report earnings for its fourth quarter.

    • PDS Biotechnology (NASDAQ:PDSB) is projected to report earnings for its fourth quarter.

    • X Financial (NYSE:XYF) is estimated to report earnings for its fourth quarter.

    • Leju Holdings (NYSE:LEJU) is projected to report earnings for its Fiscal Year 2021.

    • Stratus Properties (NASDAQ:STRS) is expected to report earnings for its fourth quarter.

    • Lottery.com (NASDAQ:LTRY) is likely to report quarterly loss at $0.02 per share on revenue of $28.42 million.

    • Nano X Imaging (NASDAQ:NNOX) is projected to report quarterly loss at $0.33 per share on revenue of $750.00 thousand.

    • Minim (NASDAQ:MINM) is expected to report quarterly loss at $0.03 per share on revenue of $17.77 million.

    • Sharecare (NASDAQ:SHCR) is likely to report quarterly loss at $0.03 per share on revenue of $121.05 million.

    • Nano Dimension (NASDAQ:NNDM) is expected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • SuperCom (NASDAQ:SPCB) is projected to report quarterly loss at $0.10 per share on revenue of $3.20 million.

    • Redwire (NYSE:RDW) is expected to report earnings for its fourth quarter.

    • Digital Brands Group (NASDAQ:DBGI) is estimated to report earnings for its fourth quarter.

    • Ensysce Biosciences (NASDAQ:ENSC) is expected to report quarterly loss at $0.02 per share on revenue of $1.00 million.

    • OMNIQ (NASDAQ:OMQS) is likely to report quarterly loss at $0.41 per share on revenue of $23.34 million.

    • INVO Bioscience (NASDAQ:INVO) is projected to report quarterly loss at $0.22 per share on revenue of $210.00 thousand.

    • Blackboxstocks (NASDAQ:BLBX) is projected to report quarterly loss at $0.05 per share on revenue of $1.53 million.

    • Inhibikase Therapeutics (NASDAQ:IKT) is likely to report quarterly loss at $0.17 per share on revenue of $300.00 thousand.

    • Nuvve Holding (NASDAQ:NVVE) is likely to report quarterly loss at $0.35 per share on revenue of $3.81 million.

    • AgileThought (NASDAQ:AGIL) is likely to report quarterly loss at $0.08 per share on revenue of $42.50 million.

    • Kidpik (NASDAQ:PIK) is likely to report quarterly loss at $0.26 per share on revenue of $5.04 million.

    • Charah Solns (NYSE:CHRA) is projected to report quarterly earnings at $0.06 per share on revenue of $84.11 million.

    • PyroGenesis Canada (NASDAQ:PYR) is likely to report earnings for its fourth quarter.

    • Draganfly (NASDAQ:DPRO) is estimated to report earnings for its fourth quarter.

    • Wejo Gr (NASDAQ:WEJO) is estimated to report quarterly loss at $0.21 per share on revenue of $2.05 million.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its fourth quarter.

    • Statera BioPharma (NASDAQ:STAB) is projected to report earnings for its fourth quarter.

    • Vislink Technologies (NASDAQ:VISL) is estimated to report earnings for its fourth quarter.

    • Arco Platform (NASDAQ:ARCE) is estimated to report quarterly earnings at $0.31 per share on revenue of $84.83 million.

    • Calithera Biosciences (NASDAQ:CALA) is likely to report earnings for its fourth quarter.

    • Aehr Test Systems (NASDAQ:AEHR) is expected to report quarterly earnings at $0.14 per share on revenue of $15.14 million.

    • Chicken Soup for the Soul (NASDAQ:CSSE) is estimated to report quarterly loss at $0.51 per share on revenue of $36.09 million.

    • Lulus Fashion Lounge (NASDAQ:LVLU) is likely to report quarterly loss at $0.07 per share on revenue of $92.75 million.

    • Spero Therapeutics (NASDAQ:SPRO) is projected to report quarterly loss at $0.75 per share on revenue of $4.95 million.

    • Remark Hldgs (NASDAQ:MARK) is likely to report earnings for its fourth quarter.

    • Pulse Biosciences (NASDAQ:PLSE) is likely to report quarterly loss at $0.51 per share on revenue of $870.00 thousand.

    • Reed's (NASDAQ:REED) is expected to report quarterly loss at $0.04 per share on revenue of $13.02 million.

    • VirTra (NASDAQ:VTSI) is expected to report quarterly earnings at $0.05 per share on revenue of $6.14 million.

    • GSE Systems (NASDAQ:GVP) is projected to report earnings for its fourth quarter.

    • Afya (NASDAQ:AFYA) is projected to report quarterly earnings at $0.18 per share on revenue of $104.76 million.

    • BlackBerry (NYSE:BB) is projected to report quarterly loss at $0.04 per share on revenue of $237.17 million.

    • Presidio Property Trust (NASDAQ:SQFT) is likely to report quarterly loss at $0.09 per share on revenue of $5.37 million.

    • Verb Tech (NASDAQ:VERB) is expected to report quarterly loss at $0.10 per share on revenue of $3.18 million.

    • voxeljet (NASDAQ:VJET) is expected to report quarterly loss at $0.04 per share on revenue of $11.10 million.

    • Arcimoto (NASDAQ:FUV) is likely to report quarterly loss at $0.26 per share on revenue of $1.48 million.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is projected to report quarterly loss at $0.04 per share on revenue of $2.82 million.

    • Biocept (NASDAQ:BIOC) is expected to report quarterly loss at $0.19 per share on revenue of $11.11 million.

    • Rekor Systems (NASDAQ:REKR) is likely to report quarterly loss at $0.21 per share on revenue of $2.75 million.

    • Duck Creek Technologies (NASDAQ:DCT) is likely to report quarterly earnings at $0.01 per share on revenue of $72.75 million.

    • GreenBox POS (NASDAQ:GBOX) is expected to report quarterly loss at $0.06 per share on revenue of $9.75 million.

    • Hill International (NYSE:HIL) is expected to report earnings for its fourth quarter.

    • LMP Automotive Holdings (NASDAQ:LMPX) is likely to report earnings for its fourth quarter.

    • Pioneer Power Solutions (NASDAQ:PPSI) is likely to report quarterly loss at $0.06 per share on revenue of $5.97 million.

    • Shapeways Hldgs (NYSE:SHPW) is projected to report quarterly loss at $0.11 per share on revenue of $7.43 million.

    • Greenbrook TMS (NASDAQ:GBNH) is projected to report quarterly loss at $0.40 per share on revenue of $12.70 million.

    • Ncino (NASDAQ:NCNO) is likely to report quarterly loss at $0.09 per share on revenue of $69.31 million.

    • Planet Labs (NYSE:PL) is expected to report earnings for its fourth quarter.

    • Astra Space (NASDAQ:ASTR) is likely to report quarterly loss at $0.25 per share on revenue of $1.17 million.

    • Blend Labs (NYSE:BLND) is expected to report quarterly loss at $0.19 per share on revenue of $82.92 million.

    • Alta Equipment Group (NYSE:ALTG) is likely to report quarterly earnings at $0.04 per share on revenue of $300.40 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACTG
    $ADMP
    $AEHR
    $AFMD

    CompanyDatePrice TargetRatingAnalyst
    Afya Limited
    $AFYA
    2/24/2026$17.00Buy → Neutral
    BofA Securities
    Afya Limited
    $AFYA
    2/13/2026$16.00Equal-Weight → Underweight
    Morgan Stanley
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Inhibikase Therapeutics Inc.
    $IKT
    1/21/2026$6.00Buy
    BofA Securities
    Afya Limited
    $AFYA
    1/16/2026$16.00Buy → Neutral
    UBS
    Afya Limited
    $AFYA
    1/7/2026$22.00Overweight → Neutral
    Analyst
    Inhibikase Therapeutics Inc.
    $IKT
    12/26/2025$8.00Buy
    H.C. Wainwright
    Redwire Corporation
    $RDW
    12/19/2025Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Afya downgraded by BofA Securities with a new price target

    BofA Securities downgraded Afya from Buy to Neutral and set a new price target of $17.00

    2/24/26 7:40:53 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Afya downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Afya from Equal-Weight to Underweight and set a new price target of $16.00

    2/13/26 8:27:42 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Draganfly Announces Closing of US$50.0 Million Registered Direct Offering

    Saskatoon, SK., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8A) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the closing of its previously announced registered direct offering of 7,150,000 common shares (or pre-funded warrants in lieu thereof) of the Company at a price of US$7.00, for gross proceeds of approximately US$50.0 million, before deducting placement agent discounts and offering expenses (the "Offering"). Maxim Group LLC acted as lead placement agent for the Offering. Raymond James Ltd. and Ladenburg Thalmann & Co. Inc. acted as co-placement agents for the Offering. Dr

    2/27/26 4:10:00 PM ET
    $DPRO
    Aerospace
    Industrials

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Redwire Corporation

    10-K - Redwire Corp (0001819810) (Filer)

    2/27/26 5:15:43 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    Ensysce Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

    2/27/26 4:30:54 PM ET
    $ENSC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sullivan Kathryn M

    4 - WELLTOWER INC. (0000766704) (Issuer)

    2/27/26 5:04:48 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Director Gundlach Andrew

    4 - WELLTOWER INC. (0000766704) (Issuer)

    2/27/26 5:01:28 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    Director Spisso Johnese was granted 1,056 shares, increasing direct ownership by 7% to 16,057 units (SEC Form 4)

    4 - WELLTOWER INC. (0000766704) (Issuer)

    2/27/26 4:59:47 PM ET
    $WELL
    Real Estate Investment Trusts
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    FDA Approval for XACIATO issued to DARE BIOSCIENCE INC

    Submission status for DARE BIOSCIENCE INC's drug XACIATO (ORIG-1) with active ingredient CLINDAMYCIN PHOSPHATE has changed to 'Approval' on 12/07/2021. Application Category: NDA, Application Number: 215650, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/7/21 12:35:25 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brown Jeffrey Dale bought $30,724 worth of shares (6,860 units at $4.48), increasing direct ownership by 6% to 60,623 units (SEC Form 4)

    4 - VirTra, Inc (0001085243) (Issuer)

    2/17/26 9:15:11 AM ET
    $VTSI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Chief Executive Officer Heilbron Jack Kendrick bought $28,200 worth of Common Stock - Series A (10,000 units at $2.82) (SEC Form 4)

    4 - Presidio Property Trust, Inc. (0001080657) (Issuer)

    12/30/25 11:39:41 AM ET
    $SQFT
    Real Estate Investment Trusts
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Leadership Updates

    Live Leadership Updates

    View All

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    Public Storage Announces PS4.0™ — A New Era of Leadership, Growth and Value Creation

    Public Storage's Fourth Era of Leadership, PS4.0, Set to Launch PS Next™ Operating Platform, Value Creation Engine and Own It Culture with Strategic Alignment to Long-Term Value Creation Tom Boyle to Succeed Joe Russell as Chief Executive Officer Effective April 1, 2026 Shankh Mitra to Succeed Ron Havner as non-executive Chairman of the Board Effective April 1, 2026 Shankh Mitra Invested $25 million and Ron Havner Invested $5 million in 10 Year Out-of-the-Money Options Demonstrating Their Confidence in and Commitment to the New Leadership Team Joe Fisher to Join Public Storage as President, Chief Financial Officer Natalia Johnson Promoted to President, Chief Digital and Transforma

    2/12/26 4:05:00 PM ET
    $PSA
    $WELL
    Real Estate Investment Trusts
    Real Estate

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Smith-Midland Corporation

    SC 13D/A - SMITH MIDLAND CORP (0000924719) (Subject)

    12/10/24 3:10:37 PM ET
    $SMID
    Building Materials
    Industrials

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    $ACTG
    $ADMP
    $AEHR
    $AFMD
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Alta Equipment Group Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Adjusted EBITDA Guidance for 2026

    Fourth Quarter Financial Highlights: (comparisons are year over year) Total revenues increased 2.2% year over year to $509.1 millionConstruction and Material Handling revenues of $328.6 million and $167.8 million, respectivelyNew and used equipment sales increased 4.8% to $300.9 million, an increase of $90.8 million, or 43.0%, sequentiallyProduct support revenues stable year over year with Parts sales increasing to $68.1 million and Service revenues increasing to $59.3 millionNet loss available to common stockholders of $(12.5) million compared to $(11.4) million in 2024Basic and diluted net loss per share of $(0.39) compared to $(0.34) in 2024Adjusted basic and diluted pre-tax net loss per

    2/26/26 4:15:00 PM ET
    $ALTG
    Industrial Machinery/Components
    Industrials

    Redwire Corporation Reports Fourth Quarter and Full Year 2025 Financial Results, Achieves Top End of 2025 Revenue Guidance Range with Record Contracted Backlog

    Redwire Corporation (NYSE:RDW, "Redwire" or the "Company")), a global leader in space and defense technology solutions, today announced results for its fourth quarter and full year ended December 31, 2025. "2025 marked the transformation of Redwire into an integrated, multi-domain space and defense tech company. This evolution is reflected in our new structure, which we believe will enable us to maintain strong positioning and continue our growth trajectory across both established and rapidly emerging domains," stated Peter Cannito, Chairman and Chief Executive Officer of Redwire. "With continued acceleration in contract awards during the fourth quarter of 2025 and confidence provided by

    2/25/26 4:30:00 PM ET
    $RDW
    Military/Government/Technical
    Industrials